Holen Sie sich die Stockscreener-App
111.08
0.99%
1.09
Handel nachbörslich:
111.08
Schlusskurs vom Vortag:
$109.99
Offen:
$110.66
24-Stunden-Volumen:
171.22K
Relative Volume:
0.84
Marktkapitalisierung:
$2.53B
Einnahmen:
$249.60M
Nettoeinkommen (Verlust:
$57.73M
KGV:
44.19
EPS:
2.5139
Netto-Cashflow:
$74.47M
1W Leistung:
+0.21%
1M Leistung:
+21.56%
6M Leistung:
+31.21%
1J Leistung:
+30.56%
1-Tages-Spanne:
$109.00
$111.77
1-Wochen-Bereich:
$104.00
$111.77
52-Wochen-Spanne:
$71.42
$115.33
Lemaitre Vascular Inc Stock (LMAT) Company Profile
Firmenname
Lemaitre Vascular Inc
Sektor
Telefon
781-221-2266
Adresse
63 SECOND AVENUE, BURLINGTON, MA
Compare LMAT vs ISRG, BDX, ALC, MDLN, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LMAT
Lemaitre Vascular Inc
|
111.08 | 2.51B | 249.60M | 57.73M | 74.47M | 2.5139 |
ISRG
Intuitive Surgical Inc
|
469.98 | 167.61B | 10.06B | 2.88B | 2.49B | 7.876 |
BDX
Becton Dickinson Co
|
158.27 | 44.35B | 21.92B | 1.76B | 2.63B | 6.1223 |
ALC
Alcon Inc
|
75.26 | 36.19B | 10.40B | 980.00M | 1.61B | 1.9749 |
MDLN
Medline Inc
|
42.67 | 34.11B | 28.43B | 1.16B | 1.26B | 1.4457 |
RMD
Resmed Inc
|
226.31 | 33.24B | 5.40B | 1.49B | 1.78B | 10.12 |
Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-06 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2025-02-28 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2025-02-28 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2025-02-13 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-10-15 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2024-08-02 | Fortgesetzt | Lake Street | Buy |
| 2024-05-31 | Fortgesetzt | ROTH MKM | Buy |
| 2024-04-26 | Hochstufung | Stifel | Hold → Buy |
| 2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Sector Weight |
| 2023-10-23 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-09-06 | Eingeleitet | Oppenheimer | Outperform |
| 2023-08-03 | Herabstufung | Jefferies | Buy → Hold |
| 2023-05-03 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2022-10-28 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2021-09-16 | Eingeleitet | Jefferies | Buy |
| 2021-02-12 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-03-16 | Hochstufung | Sidoti | Neutral → Buy |
| 2019-10-24 | Herabstufung | First Analysis Sec | Strong Buy → Outperform |
| 2019-10-24 | Hochstufung | Lake Street | Hold → Buy |
| 2019-10-14 | Hochstufung | First Analysis Sec | Outperform → Strong Buy |
| 2019-07-25 | Bestätigt | Barrington Research | Outperform |
| 2019-07-25 | Hochstufung | First Analysis Sec | Neutral → Outperform |
| 2018-10-08 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2018-10-08 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2018-06-08 | Fortgesetzt | ROTH Capital | Buy |
| 2018-04-26 | Herabstufung | Stifel | Buy → Hold |
| 2018-04-26 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2017-10-27 | Herabstufung | First Analysis Sec | Overweight → Equal-Weight |
| 2017-10-27 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2017-07-10 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2017-07-10 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2017-03-21 | Eingeleitet | First Analysis Sec | Overweight |
| 2017-02-22 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2016-09-22 | Herabstufung | Sidoti | Buy → Neutral |
| 2016-07-28 | Bestätigt | Barrington Research | Outperform |
| 2016-02-25 | Bestätigt | Barrington Research | Outperform |
Alle ansehen
Lemaitre Vascular Inc Aktie (LMAT) Neueste Nachrichten
69,202 Shares in LeMaitre Vascular, Inc. $LMAT Bought by Tudor Investment Corp ET AL - MarketBeat
LeMaitre Vascular, Inc. (LMAT): A bull case theory - MSN
LeMaitre Vascular, Inc. $LMAT Shares Acquired by Congress Asset Management Co. - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Stock Passes Above 200-Day Moving AverageWhat's Next? - MarketBeat
LeMaitre Vascular (LMAT)'s technical outlook is bright after key golden cross - MSN
LeMaitre Vascular declares $0.20 dividend - MSN
Assessing LeMaitre Vascular (LMAT) Valuation After Strong Recent Share Price Momentum - simplywall.st
LeMaitre Vascular Inc (NASDAQ:LMAT) Passes Key Quality Investing Screens - ChartMill
Insider Sell: David Roberts Sells Shares of LeMaitre Vascular In - GuruFocus
LeMaitre Vascular (LMAT) SVP exercises options, sells 2,625 shares - Stock Titan
LeMaitre Vascular (LMAT) president sells 3,311.68 shares in open market trade - Stock Titan
Kennedy Capital Management LLC Has $18.89 Million Holdings in LeMaitre Vascular, Inc. $LMAT - MarketBeat
3 Healthcare Stocks to Avoid in 2026: Analysis of UnderperformersNews and StatisticsIndexBox - IndexBox - Market Intelligence Platform
LeMaitre (NASDAQ: LMAT) CFO exercises dividend rights and uses shares for taxes - Stock Titan
LMAT (NASDAQ) Form 144: Trent Kamke plans sale of 2,625 shares via option exercise - Stock Titan
Director sale: 8,464 shares by David B. Roberts (LMAT) - Stock Titan
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Announces Quarterly Dividend of $0.25 - MarketBeat
First Trust Advisors LP Grows Stock Holdings in LeMaitre Vascular, Inc. $LMAT - MarketBeat
Stronger 2025 Results, Higher Dividend and Buyback Might Change The Case For Investing In LeMaitre Vascular (LMAT) - simplywall.st
Why Is LeMaitre Vascular, Inc. (LMAT) Stock Down Today? - Meyka
Avoiding Lag: Real-Time Signals in (LMAT) Movement - Stock Traders Daily
LeMaitre Vascular Stock Forms Golden Cross, Signals Bullish Breakout Ahead - Markets Mojo
LeMaitre Vascular Experiences Revision in Its Stock Evaluation Amid Competitive Market Dynamics - Markets Mojo
Is LeMaitre Vascular Inc. stock a safe haven assetTrade Exit Summary & Verified Momentum Watchlists - Naître et grandir
Is LeMaitre Vascular Inc stock showing strong momentumMarket Trend Review & Low Risk Entry Point Guides - baoquankhu1.vn
LeMaitre Vascular Hits Day High with 24.41% Surge in Stock Price - Markets Mojo
LeMaitre Vascular, Inc. $LMAT Shares Sold by JPMorgan Chase & Co. - MarketBeat
LeMaitre Vascular Stock: Why Wall Street Sees $109 Mean Target - TIKR.com
Lemaitre Vascular Stock Quote, Share Price, News and Analysis - Longbridge
Insider Selling: LeMaitre Vascular (NASDAQ:LMAT) CEO Sells $16,014,000.00 in Stock - Defense World
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Average Rating of "Hold" from Analysts - MarketBeat
LeMaitre Vascular Experiences Revision in Stock Evaluation Amid Strong Performance Metrics - Markets Mojo
LeMaitre Vascular Hits New 52-Week High at $115.33, Up 46.41% - Markets Mojo
LMAT SEC FilingsLemaitre Vasculr 10-K, 10-Q, 8-K Forms - Stock Titan
LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Strong Buy Ratings Amid Steady Revenue Growth - DirectorsTalk Interviews
Lemaitre Vascular SVP Kamke sells $115k in LMAT stock By Investing.com - Investing.com Australia
LeMaitre (NASDAQ: LMAT) director gains PSU-based stock and dividend rights - Stock Titan
LeMaitre Vascular (NASDAQ:LMAT) CEO Sells $6,029,813.30 in Stock - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Director Sells $903,955.20 in Stock - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) CEO Sells $16,014,000.00 in Stock - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Insider Sells $115,142.76 in Stock - MarketBeat
Lemaitre Vascular SVP Kamke sells $115k in LMAT stock - Investing.com
LeMaitre Vascular (LMAT) president reports sale of 8,464 shares - Stock Titan
LeMaitre Vascular (LMAT) director gains stock through PSU vesting and dividend rights - Stock Titan
LMAT (LMAT) CEO LeMaitre reports 205,930-share sale, PSU vesting and gift - Stock Titan
George W. LeMaitre sells 150,000 shares (LMAT) in Form 144 - Stock Titan
LeMaitre Vascular (LMAT)'s Technical Outlook is Bright After Key Golden Cross - sharewise.com
LeMaitre Vascular (LMAT) Is Up 16.4% After Dividend Hike And Buyback Plan – Has The Bull Case Changed? - Yahoo Finance
LeMaitre Vascular (LMAT) Shows Promising Technical Prospects Following Significant Golden Cross - Bitget
How The LeMaitre Vascular (LMAT) Investment Story Is Evolving With New Targets And Guidance - Yahoo Finance
LeMaitre Vascular Links Strong 2025 Results To Higher Shareholder Returns - Sahm
Finanzdaten der Lemaitre Vascular Inc-Aktie (LMAT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.95%
0.04%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):